{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:28:56Z","timestamp":1790162936358,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/hjh.0b013e3282f063d5","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T19:06:23Z","timestamp":1236107183000},"page":"2463-2470","source":"Crossref","is-referenced-by-count":66,"title":["Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima\u2013media thickness"],"prefix":"10.1097","volume":"25","author":[{"given":"Alberto","family":"Zanchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansjoerg","family":"Baurecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Cuspidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Carugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210208","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isoemaa","year":"2001","journal-title":"Diabetes Care"},{"key":"R2-15-20210208","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","article-title":"Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention study","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"R3-15-20210208","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11892-004-0013-9","article-title":"Cardiovascular risk associated with the metabolic syndrome","volume":"4","author":"Lindsay","year":"2004","journal-title":"Curr Diab Rep"},{"key":"R4-15-20210208","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.jacc.2003.12.049","article-title":"Prognostic value of the metabolic syndrome in essential hypertension","volume":"43","author":"Schillaci","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R5-15-20210208","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.CIR.0000136581.59584.0E","article-title":"C-reactive protein, the metabolic syndrome and prediction of cardiovascular events in the Framingham offspring study","volume":"110","author":"Rutter","year":"2004","journal-title":"Circulation"},{"key":"R6-15-20210208","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","article-title":"Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and all cause in United States adults","volume":"110","author":"Malik","year":"2004","journal-title":"Circulation"},{"key":"R7-15-20210208","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/01.CIR.0000140762.04598.F9","article-title":"National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study","volume":"110","author":"Hunt","year":"2004","journal-title":"Circulation"},{"key":"R8-15-20210208","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archinte.164.10.1066","article-title":"Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non diabetic European men and women","volume":"164","author":"Hu","year":"2004","journal-title":"Arch Intern Med"},{"key":"R9-15-20210208","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diacare.28.2.385","article-title":"The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study","volume":"28","author":"McNeill","year":"2005","journal-title":"Diabetes Care"},{"key":"R10-15-20210208","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/CIRCULATIONAHA.104.516948","article-title":"Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study","volume":"112","author":"Dekker","year":"2005","journal-title":"Circulation"},{"key":"R11-15-20210208","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.HYP.0000251933.22091.24","article-title":"Metabolic syndrome in the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study. Daily life blood pressure, cardiac damage, and prognosis","volume":"49","author":"Mancia","year":"2007","journal-title":"Hypertension"},{"key":"R12-15-20210208","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"R13-15-20210208","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2337\/diacare.27.2.538","article-title":"Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort","volume":"27","author":"McKeown","year":"2004","journal-title":"Diabetes Care"},{"key":"R14-15-20210208","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ecl.2004.03.005","article-title":"The metabolic syndrome: prevalence in worldwide populations","volume":"33","author":"Cameron","year":"2004","journal-title":"Endocrinol Metab Clin N Am"},{"key":"R15-15-20210208","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.annepidem.2004.01.002","article-title":"Prevalence of nontraditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"14","author":"Muntner","year":"2004","journal-title":"Ann Epidemiol"},{"key":"R16-15-20210208","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2005.01.002","article-title":"Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose","volume":"181","author":"Ford","year":"2005","journal-title":"Atherosclerosis"},{"key":"R17-15-20210208","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1097\/00004872-200410000-00023","article-title":"Metabolic syndrome and target organ damage in untreated essential hypertensives","volume":"22","author":"Cuspidi","year":"2004","journal-title":"J Hypertens"},{"key":"R18-15-20210208","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2796.2005.01468.x","article-title":"Metabolic syndrome is associated with early signs of organ damage in non diabetic, hypertensive patients","volume":"257","author":"Leoncini","year":"2005","journal-title":"J Int Med"},{"key":"R19-15-20210208","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjcard.2003.09.009","article-title":"Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study)","volume":"9","author":"Chinali","year":"2004","journal-title":"Am J Cardiol"},{"key":"R20-15-20210208","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0895-7061(03)01009-4","article-title":"Association between microalbuminuria and the metabolic syndrome: NHANES III","volume":"16","author":"Palaniappan","year":"2003","journal-title":"Am J Hypertens"},{"key":"R21-15-20210208","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann Intern Med"},{"key":"R22-15-20210208","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jacc.2003.10.061","article-title":"Metabolic syndrome amplifies the age-associated increase in vascular thickness and stiffness","volume":"43","author":"Scuteri","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R23-15-20210208","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1464-5491.2002.00719.x","article-title":"Insulin resistance in nondiabetic subjects is associated with increased incidence of myocardial infarction and death","volume":"19","author":"Hedblad","year":"2002","journal-title":"Diabet Med"},{"key":"R24-15-20210208","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1161\/01.ATV.20.9.2140","article-title":"The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study","volume":"20","author":"Hulthe","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R25-15-20210208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.hjh.0000194119.42722.21","article-title":"New-onset diabetes and antihypertensive drugs","volume":"24","author":"Mancia","year":"2006","journal-title":"J Hypertens"},{"key":"R26-15-20210208","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/01.CIR.0000039288.86470.DD","article-title":"Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial","volume":"106","author":"Zanchetti","year":"2002","journal-title":"Circulation"},{"key":"R27-15-20210208","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00004872-200406000-00022","article-title":"Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA)","volume":"22","author":"Zanchetti","year":"2004","journal-title":"J Hypertens"},{"key":"R28-15-20210208","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NNCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Final report.","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"R29-15-20210208","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2337\/diacare.27.3.788","article-title":"Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study","volume":"27","author":"Palaniappan","year":"2004","journal-title":"Diabetes Care"},{"key":"R30-15-20210208","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/00004872-200308000-00022","article-title":"Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study)","volume":"21","author":"Lindholm","year":"2003","journal-title":"J Hypertens"},{"key":"R31-15-20210208","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R32-15-20210208","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a noncalcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil\u2013Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"R33-15-20210208","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-200712000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:39:47Z","timestamp":1786037987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-200712000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e3282f063d5","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}